F18.250

Clinical Causes: Repeated and prolonged use of inhalant substances such as volatile solvents, aerosols, gases, or nitrites. Genetic predisposition that may increase vulnerability to substance dependence and psychosis. Environmental factors, including peer influence and availability of inhalants. Underlying mental health issues, like anxiety or depression, leading to the use of inhalants as a form of self-medication.

Key Symptoms: Strong and uncontrollable urge or craving to inhale substances. Inhalant dependence characterized by an inability to stop using despite negative consequences. Delusions, which are false beliefs not based in reality, often involving paranoia or misinterpretations of the environment. Hallucinations, particularly auditory or visual, during or following inhalant use. Altered mental state, including confusion, disorientation, or agitation. Possible physical symptoms such as dizziness, headache, nausea, or chemical burns around the mouth and nose.

Diagnosis Path: Diagnosis involves a comprehensive clinical assessment by a healthcare provider, which includes evaluating the patient's history of inhalant use, mental status examination, and identification of psychotic symptoms such as delusions. Healthcare professionals may also perform laboratory tests to detect inhalant substances in blood or urine. Differential diagnosis is important to rule out other mental health disorders or substance abuse issues.

Treatment Protocols: Managing this condition typically involves a multidisciplinary approach that includes pharmacological and psychosocial interventions. Treatment options include: - **Detoxification:** Monitoring and managing withdrawal symptoms if present. - **Psychotherapies:** Such as cognitive-behavioral therapy (CBT), which helps individuals recognize and change patterns of inhalant use and address the delusions. - **Medication:** Antipsychotic drugs may be prescribed to reduce psychotic symptoms; however, treatment plans are tailored to individual needs. - **Supportive therapies:** Including family therapy and peer support groups to promote recovery and prevent relapse. - **Addressing underlying factors:** Managing co-occurring mental health conditions or social issues that contribute to inhalant dependence. Early intervention and continuous support are crucial to improving outcomes and preventing long-term mental health problems.